Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus - Related Studies

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus (PUMP)

This study is ongoing, but not recruiting participants.

Study NCT00607087. Last updated on September 4, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetes Mellitus, Type 1

2	Additional conditions recognized in this trial
		Diabetes Mellitus

3	More general conditions related to this trial
		Autoimmune Diseases
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Immune System Diseases
		Metabolic Diseases

4	Interventions listed in this trial
		Insulin glulisine
		Insulin lispro
		Insulin aspart

5	Additional drug interventions recognized in this trial
		Insulin
		Insulin, Asp(B28)-

6	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Sanofi-Aventis